PFIZER — Pfizer Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹195.53bn
- IN₹173.52bn
- IN₹21.93bn
- 97
- 13
- 41
- 50
Annual cashflow statement for Pfizer, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6,425 | 6,687 | 7,729 | 8,240 | 7,461 |
| Depreciation | |||||
| Non-Cash Items | -1,568 | -549 | -383 | -2,368 | -1,516 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2,658 | -2,959 | -1,825 | -3,371 | -3,999 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3,232 | 4,273 | 6,671 | 3,557 | 2,568 |
| Capital Expenditures | -384 | -177 | -153 | -650 | -189 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 15,687 | -4,511 | -5,597 | 289 | 726 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 15,303 | -4,688 | -5,750 | -361 | 537 |
| Financing Cash Flow Items | -216 | -26.3 | -7.8 | -134 | -107 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,635 | -15,711 | -1,805 | -3,458 | -2,351 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 16,900 | -16,126 | -885 | -262 | 754 |